NIQ · NIQ Global Intelligence plc · Stock research

Current Thesis

The value-trap framing that fit this name through early August broke on 2026-08-10. Q2 2026 (quarter ended June 30) put adjusted EBITDA margin at 23.3%, up 270bp year-over-year and well clear of the 21.0% printed in Q1 — the back-half step-up the full-year guide depended on arrived a quarter early. Management raised every line: adjusted EPS from $0.95–0.99 to $1.08–1.12 against roughly $0.98 consensus, levered free cash flow to $245–255M, organic constant-currency growth to 5.2–5.6%, adjusted EBITDA margin to 23.5–23.9%. The quarter itself printed $0.27 adjusted EPS versus a $0.20 estimate on revenue of $1,124.2M versus $1.106B. Six sell-side actions landed on 2026-08-11; Needham raised to $21 on 2026-08-20. The leg an investor is buying now is a post-take-private deleveraging re-rate with an AI attach-rate narrative layered on: net leverage 3.1x at June 30 versus 3.4x at Q1, a stated sub-3.0x year-end target, levered free cash flow of $74.1M in the quarter, and AI-native solution revenue growing 34% year-over-year. What the setup no longer offers is a price that discounts any of it. The 2026-08-21 close of $18.78 is the 52-week high, RSI(14) reads 95.0, and the shares are up 119.6% over three months.

Bullish and bearish views on NIQ Global Intelligence plc

The model's bull view on NIQ Global Intelligence plc (NIQ), in brief: The margin ramp is delivered, not promised. The bear view: The GAAP line went the wrong way. Net loss attributable to NIQ was $30.5M in Q2 2026 versus $2.7M in Q2 2025 (10-Q, 2026-08-10). Net interest expense was $55.1M in the quarter and $113.6M across the first half. Refinancing is concentrated, not absent. Per the 10-Q, scheduled… Both cases follow in full.

Bull Case

• The margin ramp is delivered, not promised. Adjusted EBITDA margin 23.3% in Q2 versus 21.0% in Q1 2026, up 270bp YoY, with adjusted EBITDA growing roughly 22% on 5.8% organic constant-currency revenue growth (Q2 release and slides, 2026-08-10).
• Guidance moved up on every line at once. FY26 adjusted EPS $0.95–0.99 → $1.08–1.12; levered free cash flow $235–250M → $245–255M; OCC growth 5.0–5.3% → 5.2–5.6%; adjusted EBITDA margin 23.5–23.8% → 23.5–23.9%; reported revenue growth guided 7.1–7.4% (2026-08-10).
• Cash conversion turned positive. Levered free cash flow of $74.1M in Q2 against $3,489.4M of total debt and $416.6M of cash at 2026-06-30 (Q2 10-Q, filed 2026-08-10). Net leverage stepped to 3.1x from 3.4x at Q1.
• The AI claim carries percentages for the first time. Q2 slides disclose AI-native solution revenue +34% YoY, roughly 51% of the top-100 client base using AI-native solutions, and AI-native client growth of 64% year-to-date. Still no dollar contract values.
• Americas keeps carrying. Q2 organic constant-currency growth by region: Americas 8.3%, EMEA 4.9%, APAC 1.9% (2026-08-10 slides).
• The sell-side repriced inside ten days. 2026-08-11: UBS to $17, Stifel to $17, RBC to $17, Wells Fargo to $16.50, Deutsche Bank to $15, Needham initiating Buy at $18. 2026-08-20: Needham to $21.

Bear Case

• The GAAP line went the wrong way. Net loss attributable to NIQ was $30.5M in Q2 2026 versus $2.7M in Q2 2025 (10-Q, 2026-08-10). Net interest expense was $55.1M in the quarter and $113.6M across the first half.
• Refinancing is concentrated, not absent. Per the 10-Q, scheduled principal repayments are modest until 2030, when $3,459.0M comes due against the $3,489.4M total.
• Guidance for Q3 steps down from the Q2 run rate. Q3 revenue guided $1,105–1,108M on 4.9–5.3% growth with adjusted EPS $0.22–0.24, versus $0.27 delivered in Q2.
• Reported growth still overstates the model. Q2 reported revenue rose 8.0% (from $1,040.8M) while organic constant currency grew 5.8%; a dollar that stops weakening removes that spread.
• Growth is one region. APAC organic constant currency at 1.9% and EMEA at 4.9% mean the 8.3% Americas number is doing most of the work in the group rate.
• Price now sits above most published targets. The 2026-08-21 close of $18.78 exceeds five of the six targets set on 2026-08-11 ($15 to $17); only Needham's $21 from 2026-08-20 is higher.
• Sponsor supply has no date on it. The July 2025 IPO priced 50 million shares at $21 and raised $1.05B; Advent and KKR remain the reference holders behind 294,955,864 ordinary shares outstanding at 2026-06-30.

Setup & Price Structure

• The 2026-08-21 close of $18.78 is exactly the 52-week high — 0.0% below it — with RSI(14) at 95.0 and a three-month price change of +119.6%.
• The entire re-rate is post-print. The last completed close before Q2 was $11.68 on 2026-08-07; the move to $18.78 happened across the nine sessions following the 2026-08-10 after-close release. There is no multi-week consolidation between those two levels, so the last shelf with real time in it sits back near the pre-print area.
• The shares remain below the $21 July-2025 IPO price. The round trip to the offer level has not completed.
• The narrative is accelerating, dated by the 2026-08-10 beat-and-raise, the six-broker target cluster on 2026-08-11, and the Needham raise to $21 on 2026-08-20. The qualifier matters: that acceleration is under two weeks old and the next scheduled company event is roughly three months out.
• Crowding observables, stated as observables: RSI(14) 95.0 at the 52-week high; price above five of six published targets; Benzinga's 2026-08-20 overbought-RSI screen listing communication-sector names "you may want to dump in August"; a beat-and-raise already banked with no scheduled resolution inside 30 days. No registered secondary, block trade or insider disposal has appeared in the coverage reviewed through 2026-08-21, which leaves sponsor supply an open question rather than a confirmed event.

Catalyst Calendar (next 30 days)

• ~2026-09-03 (est.) — next monthly inflation-tracker release across the five launch markets. Dates the direction of FMCG nominal value growth, the denominator client research budgets scale to, after the 2026-08-06 print showed France in deflation at -0.4%.
• No scheduled company event falls inside 30 days of 2026-08-21. The Q2 10-Q was already filed 2026-08-10, and the Q3 print is estimated at ~2026-11-12, outside this window. Anything that moves the name before then is unscheduled: a sponsor sale, an index event, or a further rating action.

What Would Change Our Mind

The structural weakness is that nothing under the current price has been tested. The move from $11.68 (2026-08-07) to $18.78 (2026-08-21) built no base, and the raised FY26 guide — OCC 5.2–5.6%, adjusted EBITDA margin 23.5–23.9%, adjusted EPS $1.08–1.12 — is not checkable again until roughly 2026-11-12. A weekly close below $15.00 would give back the bulk of the post-print re-rate and put price back inside the $15–$17 band the sell-side set on 2026-08-11, which is the level at which the deleveraging story has stopped being priced as one. Two non-price conditions would do the same work on the fundamentals: net leverage failing to progress toward the stated sub-3.0x year-end target in the Q3 10-Q, or a Q3 print at or below the low end of the $1,105–1,108M revenue and $0.22–0.24 adjusted EPS guide, which would say the Q2 margin jump borrowed from the back half rather than reset the base. A theme flip to saturated — the rating cluster going quiet, coverage rotating to overbought screens rather than estimate revisions — would remove the flow leg without touching the numbers.

Correlation Notes

• Grouped with communication-services names in the daily movers tape (Benzinga, 2026-08-10 and 2026-08-11), so it catches sector-level flow that has nothing to do with FMCG measurement demand.
• The revenue line indexes to nominal consumer-goods value growth in its measured markets. The 2026-08-06 tracker showing France at -0.4% is a live drag on the European denominator, and EMEA organic constant currency at 4.9% in Q2 is where that shows up first.
• At 3.1x net leverage with $3,489.4M outstanding, the equity is a rate-sensitive instrument at the long end of the curve; the 2026-08-11 tape had Fed hike odds near 51% into that week's CPI, which is the macro variable that reprices the deleveraging arithmetic without any company news.
• Correlated with the 2025 sponsor-backed IPO cohort on the supply question rather than on fundamentals — a secondary anywhere in that group resets how the market handicaps Advent and KKR here.